Hospitals, Magazine and Vaccines - Pharmacy Technician Pulse

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

JUNE 13, 2025

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for continued development and distribution in low and middle-income nations. Can pharma tariffs “Make America Manufacture Again”?

Vaccines

Vaccines Communication Hospitals Packaging

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

JUNE 20, 2025

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine development by leveraging local health-tech ecosystems and research infrastructure. Can pharma tariffs “Make America Manufacture Again”? Credit: Department of Health Abu Dhabi.

Vaccines

Vaccines Communication Hospitals Packaging

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Chemotherapy

Chemotherapy Packaging Communication Hospitals

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Communication Packaging Hospitals Vaccines

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Labelling

Labelling FDA Packaging Communication

Ethris and Thermo Fisher partner on mRNA solutions

Pharmaceutical Technology

JUNE 16, 2025

mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. Can pharma tariffs “Make America Manufacture Again”? Editorial content is independently produced and follows the highest standards of journalistic integrity. Give your business an edge with our leading industry insights.

Vaccines

Vaccines Communication Hospitals Packaging

Madrigal poised to enter European MASH market after CHMP endorsement

Pharmaceutical Technology

JUNE 20, 2025

Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Packaging Insurance

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

DoH – Abu Dhabi and Sanofi link for vaccine development

Trending Sources

Big pharma braces for revenue headwinds as patent expiries loom

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

FDA approves label updates for BMS’ CAR T cell therapies

Ethris and Thermo Fisher partner on mRNA solutions

Madrigal poised to enter European MASH market after CHMP endorsement

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Piramal Pharma announces $90m investment to expand US sites

FDA approves KalVista’s Ekterly for hereditary angioedema

FDA gives TSND-201 breakthrough therapy designation for PTSD

Vertex wins European approval for Alyftrek, bolstering cystic fibrosis stronghold

DoH and Children’s National Hospital link for cell and gene therapy

Swissmedic approves Novartis’ malaria medicine for babies

FDA publishes more than 200 archived CRLs for transparency

Chugai and Gero link on antibody drugs for age-related conditions

Merck agrees to acquire Verona Pharma for $10bn

CTO East Coast 2025: Navigating shifting regulatory environment hinges on close alignment

Merck concludes SpringWorks acquisition for $3.4bn

EC approves Jazz Pharmaceuticals’ Ziihera for biliary tract cancer

Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn

Kling Bio and Sanofi link for antibodies and epitopes discovery

FDA Commissioner envisions fewer delays, more clinical trial flexibility and AI use

Lupin and Zentiva in licence and supply deal for Certolizumab Pegol

FDA approves Takeda’s Gammagard liquid ERC for primary immunodeficiency

Analysis shows Yeztugo approval a ‘momentous step’ for HIV prevention

Debiopharm and Alkyon link for radioligand therapies development

Vertex and NHS England agree reimbursement for Alyftrek

Sanofi to acquire Vicebio’s share capital for $1.15bn upfront

Health Canada extends Evkeeza approval for children with HoFH

NSW government invests $13.39m in life-changing therapies

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

FDA removes safety programme for CAR-T therapies to boost uptake

The unsustainability of clinical trials and need for transformative change

Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma

AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline

BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition

Enhancing solubility of targeted protein degraders: Better strategies for bioavailability

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

Vetter breaks ground on $285m US clinical manufacturing site

Novartis’ ribociclib approved in Canada for early breast cancer

Outlook’s wet AMD treatment accepted by SMC for NHS Scotland

Stay Connected